US Stock MarketDetailed Quotes
XTNT Xtant Medical
- 0.7500
- -0.0011-0.15%
Close May 28 16:00 ET
- 0.7700
- +0.0200+2.67%
Post 16:25 ET
97.66MMarket Cap0.00P/E (TTM)
0.8084High0.7200Low84.52KVolume0.7300Open0.7511Pre Close62.81KTurnover0.21%Turnover Ratio75.00P/E (Static)130.22MShares1.450052wk High2.05P/B30.08MFloat Cap0.620052wk Low--Dividend TTM40.11MShs Float1079.9991Historical High--Div YieldTTM11.77%Amplitude0.4291Historical Low0.7430Avg Price1Lot Size
Xtant Medical Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -156.35%-5.76M | -78.15%-9.52M | 60.01%-915K | -85.76%-3.83M | -16,906.67%-2.52M | -123.61%-2.25M | -1,316.63%-5.34M | -640.90%-2.29M | -122.89%-2.06M | -99.33%15K |
| Net income from continuing operations | -111.74%-4.4M | 107.78%660K | -94.79%-4.3M | 492.31%9.23M | -28.07%-2.19M | 6.10%-2.08M | -74.98%-8.49M | 3.24%-2.21M | -30.43%-2.35M | -133.29%-1.71M |
| Operating gains losses | -645.45%-82K | -23.66%-115K | -450.00%-11K | -1,085.71%-83K | 9.09%-10K | 84.93%-11K | -8.14%-93K | -102.56%-2K | 87.50%-7K | 85.53%-11K |
| Depreciation and amortization | 113.38%1.01M | 145.67%3.17M | 216.82%1.02M | 137.37%883K | 152.52%803K | 67.62%471K | -3.00%1.29M | 10.31%321K | 20.00%372K | -10.67%318K |
| Deferred tax | ---- | ---1.9M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non cash items | 55.56%98K | -4,864.56%-11.29M | -991.67%-535K | -17,759.68%-10.95M | 126.32%129K | 8.62%63K | 51.92%237K | -45.45%60K | 148.00%62K | 216.67%57K |
| Change In working capital | -141.72%-3.63M | -29.28%-3.63M | 202.98%1.35M | 8.64%-1.51M | -693.35%-1.96M | -739.66%-1.5M | -454.48%-2.81M | -210.58%-1.31M | -260.00%-1.66M | -85.21%331K |
| -Change in receivables | 23.90%-879K | -121.67%-8.74M | -72.52%-1.69M | -186.31%-3.93M | -94.74%-1.96M | -98.45%-1.16M | -1,135.42%-3.94M | -8.42%-979K | -351.47%-1.37M | -932.23%-1.01M |
| -Change in inventory | -610.36%-2.2M | -63.72%-1.89M | 59.51%-217K | 105.02%64K | -528.92%-1.42M | -194.50%-309K | -143.90%-1.15M | -135.83%-536K | -224.51%-1.28M | -31.83%332K |
| -Change in prepaid assets | -452.94%-376K | -15.71%220K | 586.36%151K | 276.55%399K | -148.25%-262K | 12.82%-68K | 489.55%261K | -62.71%22K | -132.99%-226K | 69.69%543K |
| -Change in payables and accrued expense | -731.03%-183K | 234.88%6.77M | 1,567.20%3.1M | 60.51%1.96M | 263.50%1.68M | -81.17%29K | 239.86%2.02M | -64.91%186K | 163.01%1.22M | -64.66%463K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -156.35%-5.76M | -78.15%-9.52M | 60.01%-915K | -85.76%-3.83M | -16,906.67%-2.52M | -123.61%-2.25M | -1,316.63%-5.34M | -640.90%-2.29M | -122.89%-2.06M | -99.33%15K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 96.13%-674K | -1,489.74%-24.78M | -448.10%-2.31M | -846.34%-4.66M | -55.12%-394K | -4,355.50%-17.42M | 17.51%-1.56M | 29.08%-422K | -44.28%-492K | 46.07%-254K |
| Net PPE purchase and sale | -60.10%-674K | 17.83%-1.28M | 38.86%-258K | 57.72%-208K | -55.12%-394K | -7.67%-421K | 17.51%-1.56M | 29.08%-422K | -44.28%-492K | 46.07%-254K |
| Net business purchase and sale | --0 | ---23.5M | ---2.06M | ---4.45M | --0 | ---17M | --0 | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 96.13%-674K | -1,489.74%-24.78M | -448.10%-2.31M | -846.34%-4.66M | -55.12%-394K | -4,355.50%-17.42M | 17.51%-1.56M | 29.08%-422K | -44.28%-492K | 46.07%-254K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 13.35%5.18M | 118.30%19.69M | -94.21%325K | 287.80%12.84M | 1,598.26%1.95M | 21,857.14%4.57M | -48.45%9.02M | 10,307.27%5.61M | 612.69%3.31M | 8.49%115K |
| Net issuance payments of debt | 22.20%5.63M | 2,141.58%5.94M | -82.34%467K | 65.40%-1.05M | 1,563.48%1.91M | 22,047.62%4.61M | 50.84%-291K | 2,049.59%2.64M | -483.62%-3.03M | -16.06%115K |
| Net common stock issuance | ---- | 50.48%14.01M | --0 | ---- | ---- | ---- | -49.47%9.31M | --2.97M | ---- | ---- |
| Net other financing activities | -1,032.50%-453K | ---261K | ---142K | ---- | ---- | ---40K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 13.35%5.18M | 118.30%19.69M | -94.21%325K | 287.80%12.84M | 1,598.26%1.95M | 21,857.14%4.57M | -48.45%9.02M | 10,307.27%5.61M | 612.69%3.31M | 8.49%115K |
| Net cash flow | ||||||||||
| Beginning cash position | -71.12%5.92M | 11.53%20.51M | -50.30%8.75M | -73.60%4.45M | -68.12%5.41M | 11.53%20.51M | 685.43%18.39M | -5.43%17.6M | -17.93%16.85M | -8.97%16.97M |
| Current changes in cash | 91.72%-1.25M | -789.06%-14.61M | -199.97%-2.9M | 475.93%4.35M | -675.81%-962K | -966.17%-15.1M | -86.79%2.12M | 1,379.30%2.9M | 139.52%756K | -106.58%-124K |
| Effect of exchange rate changes | ---49K | --24K | --77K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| End cash Position | -14.53%4.62M | -71.12%5.92M | -71.12%5.92M | -50.30%8.75M | -73.60%4.45M | -68.12%5.41M | 11.53%20.51M | 11.53%20.51M | -5.43%17.6M | -17.93%16.85M |
| Free cash flow | -141.69%-6.53M | -54.41%-10.97M | 53.20%-1.28M | -57.55%-4.06M | -843.73%-2.94M | -81.52%-2.7M | -323.93%-7.11M | -1,245.32%-2.73M | -92.74%-2.58M | -118.17%-311K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg